DrugPatentWatch Database Preview
Details for Patent: 6,793,931
Which drugs does patent 6,793,931 protect, and when does it expire?
Patent 6,793,931 protects ULESFIA and is included in one NDA.
Summary for Patent: 6,793,931
| Title: | Ectoparasite asphyxiator compositions and methods for their applications |
| Abstract: | Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems. |
| Inventor(s): | Precopio; Michael J (Collegeville, PA) |
| Assignee: | Summers Laboratories, Inc. (Collegeville, PA) |
| Application Number: | 10/195,048 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,793,931 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Use; Device; |
Drugs Protected by US Patent 6,793,931
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | TOPICAL TREATMENT OF LICE INFESTATIONS | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 6,793,931
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,294,342 | Ectoparasite asphyxiator compositions and methods for their application | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
